4-41745990-TGCCGCCGCCGCCGCTGCCGCGGCCGCC-TGCCGCC

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_003924.4(PHOX2B):​c.741_761delCGCGGCAGCGGCGGCGGCGGC​(p.Ala248_Ala254del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000354 in 1,235,952 control chromosomes in the GnomAD database, including 8 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A247A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00034 ( 8 hom. )

Consequence

PHOX2B
NM_003924.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.12

Publications

0 publications found
Variant links:
Genes affected
PHOX2B (HGNC:9143): (paired like homeobox 2B) The DNA-associated protein encoded by this gene is a member of the paired family of homeobox proteins localized to the nucleus. The protein functions as a transcription factor involved in the development of several major noradrenergic neuron populations and the determination of neurotransmitter phenotype. The gene product is linked to enhancement of second messenger-mediated activation of the dopamine beta-hydroylase, c-fos promoters and several enhancers, including cyclic amp-response element and serum-response element. Expansion of a 20 amino acid polyalanine tract in this protein by 5-13 aa has been associated with congenital central hypoventilation syndrome. [provided by RefSeq, Jul 2016]
PHOX2B Gene-Disease associations (from GenCC):
  • central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Haddad syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • neuroblastoma, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P
  • congenital central hypoventilation syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_003924.4
BP6
Variant 4-41745990-TGCCGCCGCCGCCGCTGCCGCG-T is Benign according to our data. Variant chr4-41745990-TGCCGCCGCCGCCGCTGCCGCG-T is described in ClinVar as [Likely_benign]. Clinvar id is 239591.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000457 (67/146766) while in subpopulation AMR AF = 0.000894 (13/14544). AF 95% confidence interval is 0.000529. There are 0 homozygotes in GnomAd4. There are 28 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 67 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHOX2BNM_003924.4 linkc.741_761delCGCGGCAGCGGCGGCGGCGGC p.Ala248_Ala254del disruptive_inframe_deletion Exon 3 of 3 ENST00000226382.4 NP_003915.2 Q99453

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHOX2BENST00000226382.4 linkc.741_761delCGCGGCAGCGGCGGCGGCGGC p.Ala248_Ala254del disruptive_inframe_deletion Exon 3 of 3 1 NM_003924.4 ENSP00000226382.2 Q99453
PHOX2BENST00000510424.2 linkn.*22_*42delCGCGGCAGCGGCGGCGGCGGC downstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.000450
AC:
66
AN:
146666
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000713
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000895
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000348
Gnomad OTH
AF:
0.000496
GnomAD2 exomes
AF:
0.000279
AC:
6
AN:
21500
AF XY:
0.000151
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00262
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000325
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000340
AC:
370
AN:
1089186
Hom.:
8
AF XY:
0.000325
AC XY:
170
AN XY:
522640
show subpopulations
African (AFR)
AF:
0.000454
AC:
10
AN:
22026
American (AMR)
AF:
0.000836
AC:
7
AN:
8376
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14028
East Asian (EAS)
AF:
0.0000416
AC:
1
AN:
24026
South Asian (SAS)
AF:
0.000642
AC:
15
AN:
23380
European-Finnish (FIN)
AF:
0.000109
AC:
3
AN:
27444
Middle Eastern (MID)
AF:
0.000336
AC:
1
AN:
2978
European-Non Finnish (NFE)
AF:
0.000346
AC:
320
AN:
924312
Other (OTH)
AF:
0.000305
AC:
13
AN:
42616
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
15
29
44
58
73
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000457
AC:
67
AN:
146766
Hom.:
0
Cov.:
32
AF XY:
0.000392
AC XY:
28
AN XY:
71486
show subpopulations
African (AFR)
AF:
0.000736
AC:
30
AN:
40780
American (AMR)
AF:
0.000894
AC:
13
AN:
14544
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3408
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5002
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4726
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9056
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
274
European-Non Finnish (NFE)
AF:
0.000348
AC:
23
AN:
66034
Other (OTH)
AF:
0.000490
AC:
1
AN:
2040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000385

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 09, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27535533) -

Feb 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PHOX2B: BS1 -

Haddad syndrome Benign:1
Nov 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Mar 10, 2021
Sema4, Sema4
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.1
Mutation Taster
=193/7
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs749694204; hg19: chr4-41748007; COSMIC: COSV105845467; API